[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Special Feature
November 01, 2007

Image of the Month—Diagnosis

Arch Surg. 2007;142(11):1104. doi:10.1001/archsurg.142.11.1104
Answer: PH Secondary to Unilateral Adrenal Hyperplasia

The patient underwent transperitoneal laparoscopic left adrenalectomy, which was uncomplicated. Final histologic examination of the left adrenal gland demonstrated cortical hyperplasia involving the zona glomerulosa, fasciculata, and reticularis. There was a nodular proliferation of cells that formed nested groups and trabeculae with round ovid nuclei and vesicular to clear cytoplasm. These features were compatible with adrenal hyperplasia. At a follow-up of 12 months postoperatively, the patient was cured of hypokalemia with a serum potassium concentration of 4.2 mEq/L without supplements. Her hypertension was not cured but she had improved control. Her blood pressure was 130/80 mm Hg with 50 mg of atenolol every morning and 30 mg of nifedipine every morning.

Primary hyperaldosteronism is one of the most common causes of secondary hypertension. It was first described in 1955 by Conn1as a syndrome characterized by hypertension, hypokalemia, and excessive urinary excretion of aldosterone secondary to an adrenal cortical adenoma. Aldosterone-producing adenoma and bilateral adrenal hyperplasia account for more than 95% of PH cases.2Very rarely, PH is caused by unilateral adrenal hyperplasia (UAH).3According to a recent review of 30 cases,3UAH occurs in patients with a median age of 49 years and affects mainly men (male to female ratio, 1.7:1). However, the results from another recent study of 15 patients demonstrated that the sex distribution was equal (male to female ratio, 7:8).4

Adrenal venous sampling is the most accurate test for the detection of UAH and remains the gold standard.3Postural studies are unpredictable, with a sensitivity of only 77%.3Although computed tomography successfully detected a nodule in our case, it generally only has a sensitivity ranging from 40% to 53% in correctly localizing UAH.3Adrenal scintigraphy is equally unreliable in the detection of this pathologic abnormality, with a sensitivity of 50%.3

Unilateral adrenalectomy is the treatment of choice for patients with PH secondary to UAH, as these patients demonstrate excellent outcome after surgery. At a median follow-up of 1 year, more than 95% of patients are completely cured or have improved control of their hypertension and almost all of the patients are cured of hypokalemia.3These excellent results are similar to those of unilateral adrenalectomy for PH secondary to aldosteronoma.5

Presently, although it is being increasingly recognized as a unique pathologic cause of PH, the existence of UAH remains controversial. The follow-ups of reported cases have been relatively short, with most cases followed up for less than 2 years.3It remains to be seen whether these cases of UAH will stay cured with longer follow-up or whether they will relapse and thus prove to be cases of bilateral disease. The initial success of unilateral adrenalectomy reported in some cases of bilateral adrenal hyperplasia lends support to the argument that hyperplasia of the adrenal glands in bilateral adrenal hyperplasia may occur at different times.6Hence, long-term follow-up in larger numbers of patients is required to determine whether UAH is a truly unique clinicopathologic entity or whether UAH may just represent bilateral adrenal hyperplasia presenting initially with asymmetrical hyperplasia and aldosterone production.

In conclusion, recognition of UAH as a rare cause of PH is important because it is surgically curable. Its existence lends support to the argument that adrenal venous sampling should be performed in patients with PH without localizing signs on cross-sectional imaging, as approximately half of these lesions cannot be detected on imaging.

Box Section Ref ID

Submissions

Due to the overwhelmingly positive response to the Image of the Month, the Archives of Surgeryhas temporarily discontinued accepting submissions for this feature. It is anticipated that requests for submissions will resume in mid-2008. Thank you.

Back to top
Article Information

Correspondence:Brian K. P. Goh, MBBS, MRCS, MMed (Surgery), Department of Surgery, Singapore General Hospital, Outram Road, Singapore 169608 (bsgkp@hotmail.com).

Accepted for Publication:September 12, 2006.

Author Contributions:Study concept and design: Goh. Acquisition of data: Goh, Tan, and Tran. Analysis and interpretation of data: Goh, Tan, Yip, and Cheng. Drafting of the manuscript: Goh. Critical revision of the manuscript for important intellectual content: Goh, Tan, Tran, Yip, and Cheng. Administrative, technical, and material support: Tan, Yip, and Cheng. Study supervision: Goh, Tan, Tran, and Cheng.

Financial Disclosure:None reported.

References
1.
Conn  JW Primary aldosteronism: a new clinical syndrome. J Lab Clin Med 1955;456- 17
2.
Magill  SBRaff  HShaker  JL  et al.  Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 2001;86 (3) 1066- 1071
PubMed
3.
Goh  BKTan  YHChang  KTEng  PHYip  SKCheng  CW Primary hyperaldosteronism secondary to unilateral adrenal hyperplasia: an unusual cause of surgically correctable hypertension: a review of 30 cases. World J Surg 2007;31 (1) 72- 79
PubMedArticle
4.
Novitsky  YWKercher  KWRosen  MJCobb  WAJyothinagaram  SHeniford  BT Clinical outcomes of laparoscopic adrenalectomy for lateralizing nodular hyperplasia. Surgery 2005;138 (6) 1009- 1016
PubMedArticle
5.
Goh  BKTan  YHYip  SKEng  PHCheng  CW Outcome of patients undergoing laparoscopic adenalectomy for primary hyperaldosteronism. JSLS 2004;8 (4) 320- 325
PubMed
6.
Sasagawa  INakada  THashimoto  T  et al.  Unilateral diffuse adrenal hyperplasia masquerading as aldosterone-producing adenoma in primary hyperaldosteronism. Urol Int 1993;50 (4) 218- 222
PubMedArticle
×